Literature DB >> 7904053

Free radical scavenging properties of beta-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts.

A F Rump1, R Rösen, W Klaus.   

Abstract

UNLABELLED: Several beta-adrenoceptor-blocking agents have been shown to possess free radical scavenging properties. Therefore, the direct cardioprotective properties of propranolol or pindolol were investigated in comparison to superoxide dismutase (SOD). We used isolated rabbit hearts paced at a constant rate (Langendorff, constant pressure: 70 cm H2O, Tyrode solution, Ca2+ 1.8 mmol/l). Acute regional myocardial ischemia (MI) was induced by left coronary artery branch occlusion and quantitated from epicardial NADH-fluorescence photography. Propranolol (10(-8) mol/l), pindolol (10(-6) mol/l) or SOD (48 I.U./ml) had no significant influence on left ventricular pressure, pressure-rate product or global coronary flow (p > 0.05). Whereas epicardial NADH-fluorescence area after repetitive coronary occlusions was significantly diminished by SOD-treatment (-25%) (p < 0.05), MI size was not significantly affected by either propranolol or pindolol (p > 0.05).
CONCLUSION: Oxygen-derived free radicals contribute to tissue injury during myocardial ischemia, and propranolol or pindolol do not possess free radical scavenging properties relevant for cardioprotection in a repetitive coronary occlusion model in isolated rabbit hearts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904053     DOI: 10.1007/bf00171344

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Evaluation of cardiac ischemia by NADH fluroescence photography.

Authors:  C H Barlow; A H Harken; B Chance
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

2.  Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy.

Authors:  P B Garlick; M J Davies; D J Hearse; T F Slater
Journal:  Circ Res       Date:  1987-11       Impact factor: 17.367

3.  Kinetics of mitochondrial flavoprotein and pyridine nucleotide in perfused heart.

Authors:  B Chance; I A Salkovitz; A G Kovach
Journal:  Am J Physiol       Date:  1972-07

4.  Validity of myocardial oxygen consumption parameters.

Authors:  D Baller; H J Bretschneider; G Hellige
Journal:  Clin Cardiol       Date:  1979-10       Impact factor: 2.882

Review 5.  Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.

Authors:  R A Kloner; K Przyklenk; P Whittaker
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.

Authors: 
Journal:  Eur Heart J       Date:  1985-03       Impact factor: 29.983

7.  Increase of myocardial oxygen consumption due to active diastolic wall tension.

Authors:  D Baller; H G Wolpers; A Hoeft; H Korb; A Rösick; G Hellige; H J Bretschneider
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

Review 8.  Free radicals and myocardial ischemia and reperfusion injury.

Authors:  P J Simpson; B R Lucchesi
Journal:  J Lab Clin Med       Date:  1987-07

9.  Protective effect of propranolol in threatened myocardial infarction.

Authors:  R M Norris; E D Clarke; N L Sammel; W M Smith; B Williams
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

Review 10.  Superoxide dismutase: possible therapeutic use in cardiovascular disease.

Authors:  R Ferrari; C Ceconi; S Curello; S Ghielmi; A Albertini
Journal:  Pharmacol Res       Date:  1989 Nov-Dec       Impact factor: 7.658

View more
  1 in total

1.  A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.

Authors:  A F Rump; D Acar; W Klaus
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.